Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3A pseudogene 13 (RPS3AP13) is a non-functional, processed pseudogene derived from the ribosomal protein S3A gene. Pseudogenes such as RPS3AP13 arise from gene duplication or retrotransposition events and typically do not produce functional protein products. There are multiple processed pseudogenes of the parent gene RPS3A in the human genome, but RPS3AP13 does not have a role as a therapeutic target, is not implicated in disease, and is not associated with known pharmacological agents. Occasionally, pseudogenes can have regulatory functions at the RNA level, but no such role has been clearly established for RPS3AP13[2][6][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPS3A pseudogene 13 (RPS3AP13).